U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07171814) titled 'Cohort Study of Honghua Xiaoyao Tablets in the Treatment of Premenstrual Syndrome Based on Target Trial Emulation Framework' on Sept. 06.
Brief Summary: To evaluate the efficacy and safety of Honghua Xiaoyao tablets in the treatment of premenstrual syndrome, and the results were further analyzed and evaluated by target trial simulation (TTE) framework.
Study Start Date: Sept. 30
Study Type: OBSERVATIONAL
Condition:
Premenstrual Syndrome
Intervention:
DRUG: Honghua Xiaoyao tablets
The non-exposed group (patients who did not receive Honghua Xiaoyao Tablets or other targeted drug treatments) only received routine clinical obser...